ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Title View Sessions
View by Date
Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
  • C-Reactive Protein 1-Year Post-Transplant is Associated with Future Development of Coronary Artery Vasculopathy and Rejection in a Pediatric Heart Transplant Cohort

    H. J. Tadros, A. H. Bashir, F. J. Fricker, B. A. Pietra, D. Gupta

  • Cadaveric Uterus Transplant Outcomes: Cleveland Experience

    C. Quintini1, G. D’Amico1, B. Eghtesad1, E. Richards1, C. Kwon1, K. Hashimoto1, S. Ricci1, R. Flyckt2, C. Ferrando1, A. Simioni1, L. Del Angel Diaz1, C. Miller1, T. Falcone1, A. Tzakis3

  • Calcineurin Inhibitor Withdrawal is the Significant Risk Factor for De Novo DSA Production in Living Donor Kidney Transplantation

    T. Hiramitsu1, T. Tomosugi1, K. Futamura1, M. Okada1, N. Goto1, S. Narumi1, K. Uchida2, Y. Watarai1

  • Calcium Level-Dependence of the Adverse Effect of Tertiary Hyperparathyroidism on Graft Survival in Renal Transplant Recipients

    M. Okada, T. Tomosugi, T. Hiramitsu, K. Futamura, A. Kanda, N. Goto, S. Narumi, T. Ichimori, Y. Watarai

  • Calcium Oxalate Deposition in Kidney Allografts: Clinical Chracteristics and Outcome

    S. Sritharan1, J. Kamal2, S. A. Husain1, I. Batal1, J. Chang1

  • Calcium Phosphate Crystals: An Under Recognized Cause of Kidney Allograft Injury?

    R. H. Naik, E. Ramos, B. Paueksakon, M. Anand, A. Fogo, B. P. Concepcion, M. Lusco

  • Calculated Panel Reactive Antibody Values Increase for Kidney Transplant Candidates with HLA-DQA and HLA-DPB Unacceptable Antigens

    E. P. Kransdorf1, C. Murphey2, M. Maiers3, L. Gragert4

  • Calculating the Lung Allocation Score Error for ECMO Patients

    N. Dussault1, J. Katsis2, E. Garrity1, M. M. Churpek3, W. F. Parker1

  • Calibration of Donor-Derived Cell-Free DNA Criteria for Rejection with Molecular Diagnoses of Kidney Transplant Biopsies

    I. Moinuddin1, D. Kumar1, L. Kamal1, A. King1, L. Kang1, M. Levy1, S. Bobba1, D. Massey1, P. Halloran2, G. Gupta1

  • Can a Patient with Von Willebrand Disease Donate a Kidney?

    Y. Marie1, W. McKane1, R. Maclean2, R. Pararajasingam1

  • Can Autologous Islet Cell Transplant Be a Comparable Choice to Parenchymal Preserving Surgery for Patients with Chronic Pancreatitis with Respect to Glycemic Control?

    B. M. Williams, X. Baldwin, J. S. Vonderau, M. Hanson, C. S. Desai

  • Can Biliary Internal Stents Reduce Biliary Complications in Adult Liver Transplantation?

    Y. Kwon1, Y. S. Genyk1, Y. Yoon2

  • Can Cxcr3+Cd62l–Cd4+ T Cells Serve as Early Warning Sentinels for Subclinical Rejections after Vascularized Composite Allotransplantation (vca)?

    M. Kim1, D. Fisher1, J. Loo1, J. Skitzki1, E. Repasky2

  • Can HLA-DQ Molecular Mismatch Analysis Be Used to Predict Generation of De Novo Donor-Specific Antibody at an Individual Patient Level?

    D. Pinelli1, M. Casillas Abundis1, R. Hod Dvorai2, H. McDowell1, A. R. Tambur1

  • Can Mayo Adhesive Probability Score Can Predict an Adherent Perinephric Fat? Analysis in Japanese Healthy Donor for Transplantation Underwent Laparoscopic Donor Nephrectomy

    T. Noda, Y. Miyauchi, K. Koyama, Y. Sawada, K. Nishimura, T. Fukumoto, N. Miura, T. Kikugawa, T. Saika

  • Can Organ Donor Potential Be Determined from Death Certificates? A Case Report

    S. Gunderson, J. Kemink, C. Topp, W. Payne, T. Brown, B. Welsch

  • Can Predonation Ambulatory Blood Pressure Monitoring Predict Postdonation Renal Function?

    M. Mohamed Ahmed, M. Posadas Salas, D. Taber, V. Rao, K. Soliman, M. Casey

  • Cancer Risk in Living Kidney Donors (LKDs) in the United States

    E. Engels1, K. Yu1, S. Brown1, K. Pawlish2, C. Lynch3, B. Kasiske4, J. Snyder4, R. Pfeiffer1

  • Cardiac Allograft Tolerance Can be Achieved in Non-Human Primates via Transient Mixed Hematopoietic Chimerism and Erythropoietin Administration

    K. Ahrens1, J. M. O1, W. Sommer2, J. Morrissette1, D. Becerra1, P. M. Patel1, A. Dehnadi1, T. Costa1, I. M. Hanekamp1, J. S. Allan3, P. Cravedi4, P. S. Heeger4, G. Benichou1, J. C. Madsen5

  • Cardiac Transplantation is Accompanied by Major T and NK Cell Alterations within the First 24 Hours

    J. Iske1, B. Wiegmann2, K. Ludwig1, N. Ledwoch1, E. Chichelnitskiy1, J. F. Kühne1, A. Hitz1, R. Bellmàs-Sanz1, K. Daemen1, J. Keil1, F. Ius2, S. Rochas2, A. Knoefel2, A. Haverich2, G. Warnecke2, C. S. Falk1

  • Cardiovascular Improvement after Pancreatic Transplantation

    S. Y. Suen1, T. Sparkes1, R. Kalil2, B. Ravichandran1

  • Cardiovascular Risk Factors in Patients after Liver Transplantion

    M. Adamczak1, D. Gojowy1, J. Stompor1, J. Adamusik1, G. Smiech1, H. Karkoszka1, R. Krol2, A. Wiecek1

  • Care Processes and Structures Associated with Higher Medication Adherence: The Positive Adherence Study

    A. Dabirzadeh1, B. Foster1, M. Dahhou1, S. Mital2

  • Carfilzomib-Based Desensitization: Effects on HLA, Non-HLA, Auto, and Antiviral Antibodies

    S. Tremblay1, E. Portwood1, A. R. Shields2, R. R. Alloway1, P. A. Brailey1, E. Woodle1

  • Case Series of Belatacept for Calcineurin Inhibitor Sparing after Lung Transplantation

    H. Patel, C. R. Ensor, R. D. Davis, L. Bogar, D. Colella, M. Kildea, J. Kim, A. Satterthwaite, D. Ventura, C. Gries

  • Caspase-1 Knockout Mice Have Increased Survival after Cold Ischemia in a Murine Kidney Transplant Model

    S. Jain1, R. Plenter2, T. Nydam2, A. Jani1

  • Causal Relationship between Anti-Thymocyte Globulin Induction Therapy and Development of Monomorphic PTLD in Renal Transplant Recipients

    K. Soliman1, H. Ali2, T. Fulop1, A. Osman3, A. Halawa4

  • Causes of Kidney Allograft Loss (GL) in the Current Era of Donor-Specific Alloantibody (DSA) Testing

    M. Merzkani1, X. Benavides1, M. D'Costa1, B. Smith1, W. Park1, A. Rule1, H. Chakkera2, K. Reddy2, M. Alexander1, H. Amer1, M. El Ters1, C. Schinstock1, R. Heilman2, A. Bentall1, M. Stegall1

  • CCL18 Plays a Crucial Role in T Cell Recruitment in Upper Extremity Transplant Rejection

    T. J. Borges1, P. Abarzua2, B. Kollar2, M. Lima-Filho1, B. T. Aoyama1, G. F. Murphy2, B. Pomahac2, C. G. Lian2, S. G. Talbot2, L. V. Riella1

  • CD11b is a Novel Alternate Receptor for CD154 During Alloimmunity

    M. L. Ford, D. Liu

  • CD137 Signaling in Regulatory Dendritic Cells Is Required for Suppressing a Systemic Inflammation in the bm12-Inducible Model of Systemic Lupus Erythematosus

    H. Cho1, J. Lee2, B. Kwon3, S. Park1, H. Park1, K. Yoo2, K. Park2, J. Kim3

  • CD38 Antibody Daratumumab for the Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection

    K. Doberer1, J. Kläger2, G. A. Gualdoni1, K. Mayer1, F. Eskandary1, H. Agis3, T. Reiter1, R. Reindl-Schwaighofer1, M. Wahrmann1, G. Cohen1, H. Haslacher4, G. Bond1, I. Simonitsch-Klupp5, I. Farkash6, P. Halloran7, G. A. Böhmig1

  • CD4+ T-Cells Express High Levels of Messenger RNA Coding for Heparanase in Cultures with Matrigel

    N. Chai, G. Wu, I. Kim, S. Jordan, A. Klein, T. Brennan

  • CD47 Innate Immune Checkpoint Enhances Islet Engraftment Following Intraportal Transplantation by Mitigating Instant Blood Mediated Inflammatory Reaction

    P. Shrestha, L. Batra, M. T. Malik, M. Tan, E. S. Yolcu, H. Shirwan

  • CD47/SIRPα Signaling Controls TLR4-Driven Inflammatory Response via Regulating the Akt-β-Catenin Axis in Mesenchymal Stem Cell (MSC)-Mediated Immune Regulation in Liver Ischemia and Reperfusion Injury

    M. Sheng, Y. Lin, C. Li, Y. Tian, D. Xu, Y. Zhan, A. J. Coito, D. G. Farmer, R. W. Busuttil, J. W. Kupiec-Weglinski, B. Ke

  • CD56DimCD16Bright NK Cells from Kidney Transplant Recipients with Antibody-Mediated Rejection Display Increased Proliferation, Self-Renewal, Pro-Inflammatory and Cytotoxic Profile

    E. A. Bailly1, K. Louis1, C. Macedo1, B. Ramaswami1, M. Lucas1, A. Zeevi1, C. Lefaucheur2, D. Metes1

  • CEACAM1 / ASK1 / p38 Signaling Axis Alleviates Peri-Transplant Liver Injury: From Mouse-to-Human

    H. Hirao1, K. Nakamura2, S. Kageyama1, T. Ito1, K. Kadono1, H. Kojima1, K. J. Dery1, S. Younan1, R. W. Busuttil1, F. M. Kaldas1, J. Kupiec-Weglinski1

  • Cell-Free DNA (cfDNA) is Released by Necroptosis and Promotes Kidney Ischemia Reperfusion Injury

    A. C. Dionne

  • Center Effects on Post-Transplant Outcomes in Liver Transplantation for Hilar Cholangiocarcinoma

    S. Nagai1, T. Kitajima1, G. Sapisochin2, D. Moonka1, T. Hibi3

  • Center Effects Substantially Explain Disparities in Access to Kidney Transplants, Yet DSA Effects Remain

    D. Stewart, A. Robinson, D. Klassen, A. Wilk

  • Center Performance for Liver Retransplantation Candidates is More Heterogeneous Than for Initial Liver Transplantation Recipients

    T. Bittermann, P. L. Abt, D. E. Schaubel

  • Cervical Total Arterial Anastomosis Mouse-to-Rat Heterotopic Heart Xenotransplantation

    A. Ren, Z. Li, X. Zhang, R. Deng, Y. Ma

  • CHAIR Score: A Novel Risk Stratification in Transplant Renal Artery Stenosis

    X. Tian, W. Duan, T. Yan, X. Wu

  • Challenges in Examining Transplant Outcomes in Patients with Fontan-Associated Liver Disease

    R. T. Fischer1, M. H. Kim2, A. Nguyen3, S. R. Kumar3, J. Bucuvalas4, E. F. Glynn1, M. A. Hoffman1, J. Emamaullee3

  • Challenges in Manufacturing Clinically Competent Regulatory T Cells from Obese Renal Transplant Recipients

    F. Marti, A. Ruffing, E. Chacon, L. Turcios, D. Valvi, J. Gonzalez, R. Gedaly

  • Challenges to National Kidney Paired Donation Education and Opportunities for Improvement

    A. Waterman1, E. H. Wood1, O. N. Ranasinghe1, J. L. Beaumont2, S. McGuire3, K. Miller4, V. Chipman5, J. Sinacore6, M. Cooper7

  • Challenging Dogma That Anti-Thymocyte Globulin Induction with Delayed Calcineurin Inhibitor Benefits Patients with Renal Insufficiency Undergoing Heart Transplant

    M. Kittleson, J. Patel, D. Chang, E. Kransdorf, D. Geft, K. Nishihara, A. Shen, A. Velleca, L. Czer, F. Esmailian, J. Kobashigawa

  • Change in Hypertension (HTN) Guidelines in Living Kidney Donors (LKDs) and Long-Term Renal Outcomes

    M. Merzkani1, A. Denic1, M. D'Costa1, L. Ricaurte1, R. Narasimhan1, X. Benavides1, A. Mullan1, J. Larson1, W. Kremer1, W. Park1, M. P. Alexander1, H. Chakkera2, S. Textor1, S. Taler1, M. Stegall1, N. Issa1, A. Rule1

  • Change In i-IFTA Associated with Treatment of Rejection

    N. Garg, B. C. Astor, S. Parajuli, F. Aziz, M. Mohamed, W. Zhong, A. Djamali, D. A. Mandelbrot

  • Change in the Willingness of Transplant Candidates to Accept Hepatitis C Virus Positive Deceased Donor Organs in the Era of Direct-Acting Antivirals

    Q. Yuan, S. Hong, E. Roth, M. Sise, E. Bethea, W. Williams, H. Yeh, N. Elias

  • Changes in Body Composition One Year after Hand-Assisted Laparoscopic Donor Nephrectomy in Living Kidney Donors

    H. Fukuhara1, Y. Watarai1, S. Narumi1, N. Goto1, T. Hiramitsu1, M. Okada1, K. Futamura1, T. Tomosugi1, A. Kanda1, T. Nawano1, N. Tsuchiya2

  • Changes in Gut Microbiota and Acute Rejection after Kidney Transplantation

    H. Cho1, J. Kim2, H. Kim2, J. Park3, M. Kwak4, B. Kim4, D. Kim2, J. Lee5, B. Kim6, H. Lee2

  • Changes in Health-Related Quality of Life During the First Year in Lung Transplantation Recipients

    H. Zhou, J. Chen

  • Changes in Risk Factors for Infections Post Liver Transplantation – A 16-Year Analysis

    I. Bajjoka, S. Serra, J. Mourad, M. Callaghan, C. Crombez, S. Foley, M. Abouljoud

  • Changes in the Development and Incidence of Bacterial Infections – A 16-Year Analysis

    I. Bajjoka, S. Serra, M. Jade, M. Callaghan, C. Crombez, S. Foley, M. Abouljoud

  • Characteristics and Outcomes of Acetaminophen Overdose Related Hospitalizations Requiring Liver Transplant

    A. Khan1, N. Saleem2, M. Bilal3, R. Tariq4, S. Singh5

  • Characteristics and Outcomes of Patients with Cystic Fibrosis Receiving Lung Transplant with and without ECMO Bridge – A Single Center Experience

    J. Loeb, S. Pirrotta, P. Chung, S. Ganesh

  • Characteristics Associated with Center Satisfaction in Management of the Inactive Kidney Transplant Waitlist

    J. Hiller, J. Chen, W. Zhang, A. Massie, K. Covarrubias, K. Jackson, J. Long, S. DiBrito, D. Segev, J. Garonzik-Wang

  • Characteristics of Anonymous Living Donors and Their Recipients. Appropriate Use of a Rare and Valuable Gift

    A. Sharfuddin, M. Panezai, M. Yaqub, D. Mishler, O. Adebiyi, T. Taber

  • Characteristics of Early BK Viremia after Renal Transplantation at an Urban Academic Medical Center

    K. Kurzweil, K. Lamartina, K. Svaflarska, D. Kutrzuba, N. Fayyaz, O. Piatek, P. West-Thielke, Z. Hajjiri, I. Tzvetanov, E. Benedetti, A. Lichvar

  • Characteristics of Incisional Hernia Development after Live Donor Nephrectomy: Impact of Surgical Technique

    B. J. DuBray1, J. J. Thompson2, R. C. Forbes1

  • Characteristics of Kidney Transplant Patients Diagnosed with Histoplasmosis

    C. Miles, J. Hall, S. Westphal, E. Langewisch

  • Characterization of a Clinically Scaled Bioengineered Liver Seeded with Primary Hepatocytes and Endothelial Cells

    D. S. Davidow1, J. J. Ross1, B. D. Anderson1, A. Stumbras1, A. A. Katane1, R. Lindeman1, B. G. Steiner1, A. Mendenhall1, K. Gahlbeck1, S. Armstrong1, B. P. Amiot2, E. D. Nelson2, T. Gilbert1, S. L. Nyberg2

  • Characterization of a Novel CD8+ B Cell Subset in Monkeys Tolerant of Heart Allografts

    J. A. Morrissette1, K. Pruner1, S. Lee1, J. Paster1, W. Sommer1, J. O1, I. Hanekamp1, P. Sage2, G. Benichou1, J. C. Madsen3

  • Characterization of an Integrative Prognostic Score for US Patients Taken from the DART Study

    J. Bromberg1, R. Bloom2, P. Sood3

  • Characterization of CpG-stimulated, Tlr Regulatory, and Expanded Regulatory B Cells by RNA-Seq

    Q. Fu, G. C. Rickert, K. Lee, G. Huai, K. Deng, N. Feeney, N. Tanimine, A. Cuenca, S. Deng, J. F. Markmann

  • Characterization of Donor/Recipient Citizenship Status in Adult Heart Transplantation: A UNOS Registry Analysis

    K. Yang1, D. Miklin1, J. Pizula1, P. Genyk1, G. Liu2, A. Lee1, S. Nuno1, S. Hashmi1, J. Nattiv2, A. Kiankhooy3, L. Grazette2, M. Fong2, J. Rahman2, K. Pandya2, D. Vucicevic4, J. Li1, P. Kingsford1, P. Banankhah2, R. Chand5, A. Wolfson6, S. Shah1, A. Salimbangon7, C. Lum8, E. C. Depasquale2, A. S. Vaidya2

  • Characterization of Gut Microbiome in Liver Transplant Recipients with Non-Alcoholic Steatohepatitis

    S. Sataphaty1, P. Banerjee2, J. Pierre3, R. Heda3, S. Dutta3, D. D. Higgins4, V. Mas5, S. Khan6, V. Mupparaju3, S. R. Nair7, J. D. Eason8, D. Kleiner9, D. Maluf10

  • Characterization of Histological Phenotypes of Acute Rejection Episodes in Kidney Transplant Recipient Receiving a Single 3mg/kg Dose of Rabbit Antithymocyte Globulin

    R. S. Campos1, M. Cristelli1, H. Proença2, R. D. Foresto1, L. Viana1, S. Stopa Martins1, M. Nakamura1, L. Takara1, J. Taddeo1, C. Felipe1, H. T. Tedesco Jr.1, J. Pestana1

  • Characterization of Laminin Alpha 4 Conditional Knockout Mice: Model for Immune Stimulation

    M. W. Shirkey, L. Li, W. Piao, Y. Xiong, V. Saxena, T. Zhang, C. Paluskievicz, J. Bromberg

  • Characterization of Non HLA Antibodies in Kidney Transplant Recipients

    S. Rodriguez Ramirez1, S. Clotet-Freixas1, C. Mcevoy1, M. Kotlyar2, I. Jurisica2, A. Chruscinski1, A. Konvalinka3

  • Characterization of Use and Safety of Non-Insulin Agents for Management of Post-Transplant Diabetes Mellitus in the Kidney Transplant Population

    M. Norris1, J. Trofe-Clark1, C. Sammons1, N. Casciello1, S. Cardillo2, D. Sawinski3, R. D. Bloom3, G. Malat1

  • Characterizing the Impact of Medicaid Expansion on Pediatric Liver Transplantation

    J. D. Motter, A. Kernodle, D. L. Segev, A. B. Massie

  • Characterizing the Landscape and Impact of Infections Following Kidney Transplantation

    K. R. Jackson, J. Motter, R. Avery, W. Werbel, A. Massie, J. Garonzik-Wang, D. Segev

  • Characterizing the Waitlist Candidate Who Was Bypassed by the Successfully Transplanted Candidate with Alcoholic Hepatitis

    J. Ge1, C. L. Berg2, F. Y. Yao1, J. P. Roberts3, J. C. Lai1

  • Child-Turcotte-Pugh Class at Transplantation Predicts Mortality after Heart Transplantation Following Left Ventricular Assist Device Placement

    E. Leven1, A. T. Kurdi2, S. Pinney1, T. Schiano1, J. Crismale1

  • Choice of Mitral Valve and Aortic Valve for Replacement for ESRD Patients Eligible for Kidney Transplant: A USRDS Analysis

    N. Sarabu1, D. Ngendahimana2, L. Al Dahabre3, K. Lentine4, K. Chavin1, T. Srinivas1, S. Deo2

  • Chronic Active T-Cell Mediated Rejection is Variably Responsive to Immunosuppressive Therapy

    V. Kung1, M. Haas1, M. Gillespie2, E. Huang2, R. Sandhu2

  • Chronic Diarrhea in Renal Transplant Recipients: A Metagenomic Study of Gut Microbiota Composition and Functionality

    J. C. Swarte1, R. M. Douwes1, S. Hu2, R. Gacesa2, H. J. Harmsen3, R. K. Weersma2, S. J. Bakker1

  • Chronic Hyperammonemia an Important Cause of Morbidity in Isolated Intestine Transplant Patients with Venous Outflow to the Vena Cava

    R. S. Mangus, C. A. Kubal, T. Burch, B. Ekser, P. Mihaylov, J. Fridell

  • Chronic Kidney Disease Alters the T Cell Response to Murine Cytomegalovirus

    R. L. Crepeau1, H. Li1, H. S. Koehler2, M. L. Ford1, P. D. Winterberg3

  • Chronic Lymphocytic Leukemia in a Lung Transplant Recipient

    A. Arjuna1, M. T. Olson2, S. Tokman1, S. Biswas Roy1, M. A. Smith1, R. M. Bremner1, R. Walia1

  • Cigarette Smoking and Long-Term Renal Function and Cardiovascular Disease in Living Kidney Donors

    S. Getsin1, M. Waldram1, Y. Yu1, D. Brennan1, F. Al Ammary1, J. Garonzik-Wang1, M. Henderson1, J. Locke2, R. Reed2, K. Lentine3, D. Segev1, A. Massie1

  • Circulating Exosomes with Cardiac Self-Antigens, Myosin and Vimentin, Induced Immune Responses Leading to Rejection Following Heterotopic Cardiac Transplantation Immunosuppressed with mTOR Inhibitor and Low Dose of IL-2 Therapy

    Y. Itabashi, R. Ravichandran, S. Bansal, T. Fleming, T. Mohanakumar

  • Circulating MicroRNA Signatures in Chronic Pancreatitis Patients Undergoing Total Pancreatectomy with Islet Transplantation

    S. Vasu, C. M. Darden, K. Kumano, M. Lawrence, B. Naziruddin

  • Circulating Tissue Specific Exosomes Enable Noninvasive Diagnosis of Acute Cellular Rejection in Clinical Heart Transplantation

    L. Korutla1, R. Hu1, C. Romano1, M. Molina1, C. Sciortino2, C. Mullan3, R. McGargle2, H. Kagawa2, A. Kilic2, A. Naji4, P. Vallabhajosyula3

  • Circulatory Extracellular Vesicles from Lung Allograft Recipients with Chronic Lung Allograft Dysfunction Can Induce LKB1 Dependent Epithelial-Mesenchymal Transition

    M. Rahman, S. Angara, A. Arjuna, M. Smith, R. Bremner, T. Mohanakumar

  • Cirrhosis-Driven Immune Dysfunction is Associated with Poor Response to DEB-TACE and Waitlist Dropout in Hepatocellular Carcinoma Patients While Awaiting Liver Transplantation

    K. Nunez, T. Sandow, M. Hibino, A. Cohen, P. Thevenot

  • Clazakizumab (Anti-IL-6 Monoclonal) as an Agent to Reduce Donor Specific Hla Antibodies (DSA) and Improve Outcomes in Patients with Chronic & Active Antibody-Mediated Rejection Post-Kidney Transplantation (NCT03380377)

    S. C. Jordan, N. Ammerman, M. Toyoda, S. Ge, E. Huang, A. Peng, S. Sethi, R. Najjar, E. Ortiz, M. Chu, A. De Guzman, I. Kim, K. Lim, J. Choi, A. Vo

  • Clazakizumab (Anti-IL-6) Induces Foxp3+ Tregs in Highly HLA Sensitized Patients Desensitized for HLAi Transplantation (NCT03380962)

    S. C. Jordan, S. Ge, N. Ammerman, M. Toyoda, E. Huang, A. Peng, R. Najjar, S. Sethi, S. Williamson, C. Myers, K. Lim, J. Choi, A. Vo

  • Clinical and Demographic Factors Affecting Patient and Graft Survival in Pancreas Transplant Recipients: The Efispan Study

    P. Ventura-Aguiar1, M. Cabello2, I. Beneyto3, D. Navarro Cabello4, G. Tabernero5, A. Alonso6, J. Ruiz7, S. Llorente8

  • Clinical and Laboratory Characteristics of Early and Late-Onset Cytomegalovirus Infection Following Universal Prophylaxis in Kidney Transplant Recipients

    M. M. Tavakol, B. Lee, S. Ashimine, H. Crossman, M. Park, Z. Laszik, J. Roberts

  • Clinical Correlation of Results of s CD4/CD8 Cytomegalovirus Cell Mediated Immunity Test with Incidence of Cytomegalovirus Infection

    M. Jorgenson1, M. Hillis1, C. Saddler2, J. Smith2, D. Mandelbrot2

  • Clinical Correlations Associated with Development of De Novo Donor-Specific Antibody in the First Year Following Kidney Transplant at a Single Center

    J. M. Zimmerer1, M. Basinger1, B. A. Ringwald1, R. Pelletier2, A. Rajab1, A. El-Hinnawi1, M. Abdel-Rasoul1, K. Washburn1, G. L. Bumgardner1

  • Clinical Evaluation of Lung Transplantation for End-Stage Idiopathic Pulmonary Fibrosis Patients with Lung Cancer

    J. Zhang, D. Liu, J. Chen

  • Clinical Features and Outcomes of Post-Transplant Osteomyelitis in Solid Organ Transplant Recipients

    S. Sarwar1, G. Vilchez2, M. M. Azar3, M. Malinis3

  • Clinical Features and Transplant Outcomes in Kidney Transplant Recipients with Renal Cell Carcinoma

    C. Baek, H. Kim, S. Park

  • Clinical Implication of Tertially Lymphoid Tissue in the Renal Graft

    M. Saito1, Y. Lee2, Y. Sato2, S. Narita1, S. Satoh1, M. Yanagita2, T. Habuchi1

  • Clinical Implications of Tacrolimus Time in Therapeutic Range in Urban Renal Transplant Recipients Under an Early Corticosteroid Withdrawal Protocol

    D. Pierce, P. West-Thielke, Z. Hajjiri, S. Gaitonde, I. Tzvetanov, E. Benedetti, A. Lichvar

  • Clinical Outcomes Associated with Long-Term Exposure to Airborne Particulate Pollution in Kidney Transplant Recipients

    Y. Kim1, J. Lee2

  • Clinical Outcomes from a Mobile Health, Pharmacist-Led Intervention: 12-Month Results of the Transafe Rx Randomized Controlled Trial

    D. Taber, J. Hirsch, Z. Su, J. McGillicuddy, A. Posadas, J. Fleming

  • Clinical Outcomes in Kidney Transplant Recipients Following Implementation of a Strategic Maintenance Reduction Protocol

    H. Perkins, K. Foster, N. Patel, H. Meadows, F. Bartlett, C. Perez, J. McGillicuddy, N. Pilch, M. Casey, M. A. Posadas-Salas, D. Taber

  • Clinical Performance of a Donor-Derived Cell-Free DNA Assay for Detection of Rejection in Kidney Transplant Recipients

    S. Kleiboeker, J. Grantham, K. Mickey, S. Cowden, E. Bixler, R. Sinha, M. Altrich

  • Clinical Relevance of Immunoglobulin M Deposition in Peritubular Capillaries in ABO-Incompatible Kidney Transplantation

    D. Toki1, M. Okumi2, K. Unagami2, Y. Kakuta2, H. Ishida2, K. Yamashita1, H. Tachibana1, A. Hayashida1, T. Horiuchi1, Y. Ishiyama1, K. Honda3, T. Kondo1, K. Tanabe2

  • Clinical Significance of C4d and HLA-DSA on Post-Transplant Clinical Outcomes in Kidney Transplant Recipients with Antibody-Mediated Rejection

    W. Park, O. Kwon, Y. Kim, J. Paek, K. Jin, S. Park, S. Han

  • Clinical Significance of Late Antibody-Mediated Rejection without Donor Specific Anti-hLA Antibodies

    J. Lee1, E. Kim1, S. Yang1, S. Kim1, B. Lim2, H. Choi3, B. Kim4, B. Kim4, M. Ju5, M. Kim1, S. Kim1, Y. Kim1, K. Huh1

  • Clinical Significance of T Cell and B Cell Epitope Prediction as a Risk Factor of De Novo DSA Production after Kidney Transplantation

    T. Kobayashi1, K. Iwasaki1, T. Tomosugi2, Y. Miwa1, M. Niemann3, E. Spierings4, K. Horimi1, Y. Matsuoka1, A. Takeda2, N. Goto2, S. Narumi2, Y. Watarai2

  • Clinical Study of Standard versus Reduced Dose Tacrolimus Combined with Generic Mycophenolate Mofetil in De Novo Kidney Transplantation

    J. Bang, C. Oh

  • Clinically Adjudicated Deceased Donor AKI and Graft Outcomes

    S. G. Mansour1, N. Khoury1, S. Vermani1, R. Koladi1, I. Hall2, P. Reese3, S. Mohan4, M. Doshi5, M. Harhay6, J. Bromberg7, M. Thangamani8, P. Singh9, Y. Jia10, H. Thiessen-Philbrook10, E. Akalin11, F. Weng12, B. Schroeppel13, J. Greenberg1, D. Moledina1, F. P. Wilson1, C. Parikh10

  • Clinicopathologic Features and Risk Factors of Proteinuria in Transplant Glomerulopathy: A Cross-Sectional Study

    Q. Zhang1, K. Budde1, D. Schmidt1, F. Halleck1, M. Dürr1, M. Naik1, M. Mayrdorfer1, W. Düttmann-Rehnolt1, F. Klauschen2, B. Rudolph2, K. Wu2

  • Clinicopathological Evaluation of Long-Term Survivor More Than 10 Years after Living Kidney Transplant with Corticosteroid Early Withdrawal Protocol

    H. Sasaki1, T. Tanabe1, H. Higuchi1, T. Tsujimoto2, H. Harada1

  • Cmv Infection Sensitizes Transplant Recipients by Promoting Alloreactive T Cell Response

    S. Yu, A. Dangi, X. Luo

  • CMV, EBV and BKV Viremia Rate Varied Depending on the Timing of Conversion to Belatacept (BLT)- from Calcineurin Inhibitor (CNI)-Based Immunosuppression and HLA-Sensitization (HS) Status in Kidney Transplant Patients (KTx Pts)

    B. Shin, N. Ammerman, A. Vo, S. C. Jordan, M. Toyoda, S. Sethi

  • Co-Stimulatory Blockade Immunosuppression Facilitates Lung Allograft Acceptance Through an Increase in Local IL-5 Production by Type 2 Innate Lymphoid Cells

    Y. Guo, Z. Mei, A. Hata, B. Mahgoub, D. Li, A. Manafi, A. Banerjee, A. Gelman, D. Kreisel, A. Krupnick

  • Coagulation and Cd46 Transgene Modification in Neonatal Porcine Islet Xenotransplantation

    M. Song, Z. Fitch, K. Samy, Q. Gao, R. P. Davis, F. Leopard, R. Schmitz, N. Huffman, G. Devi, B. Collins, A. D. Kirk

  • Cognitive Impairment is Highly Prevalent in Lung Transplant Candidates

    A. O'Boye, K. Leitner, M. Kelly, J. Wright, L. Pesce, M. Sala, R. Tomic

  • Combined Heart-Liver Transplantation Has Excellent Long-Term Outcomes

    J. A. Steadman1, J. M. Stulak1, A. L. Clavell2, S. S. Kushwaha2, B. S. Edwards2, N. L. Pereira2, B. A. Boilson2, A. Behfar2, R. J. Rodeheffer2, J. A. Dearani1, T. Taner3, R. C. Daly1

  • Combined Heart-Liver Transplantation: A Systematic Review of the Literature

    I. A. Ziogas1, D. Giannis2, P. Kapsampelis2, A. Giannopoulou2, A. Evangeliou2, K. S. Mylonas2, G. Tsoulfas3, L. K. Matsuoka1, M. I. Montenovo1, M. Izzy1, S. P. Alexopoulos1

  • Combined Phenotyping to Identify Kidney Transplants at Greatest Risk after Subclinical Acute Rejection

    S. Park1, R. Heilman2, E. Poggio3, D. Taber4, L. Zhao1, K. Guo1, S. Kurian5, C. Rebello1, S. Brietigam1, M. Abecassis6, J. Friedewald1

  • Combining New Biomarkers: Donor Derived Cell Free DNA (dd-cfDNA) and Transcriptomics Impacts Rejection Diagnosis, Treatment and Follow Up

    S. Anand, L. Dong, D. Miller, I. Lloyd, D. Morris, T. Srinivas

  • Combining Pharmacy and Genome-Wide Genotyping Data to Examine Medication Regimen Complexity Indices (MRCI), Drug-Drug and Gene-Drug Interactions in Transplant Patients

    L. Callans, J. Obayemi, H. Gao, A. Shaked, B. Chang, B. Keating

  • Community Affluence Impacts Patient Survival Post Liver Transplantation

    D. Jorgensen, A. Humar, C. Hughes, M. Molinari, A. Ganoza, S. Ganesh, A. Duarte-Rojo, A. Tevar

  • Comparable Outcomes for Simultaneous Liver-Kidney Transplantation with HCV NAT-Positive Donors

    M. L. Samoylova1, B. I. Shaw1, S. J. Kesseli1, L. McElroy1, Y. Patel2, S. Sanoff2, A. S. Barbas1

  • Comparative Analysis of Kidney Transplant-Specific versus Hospital-Wide Antibiograms

    J. D. Lewis

  • Comparative Analysis of Patient Outcomes between Urology-Led versus General Surgery-Led Kidney Transplant Centers

    A. Mishra1, A. Cohen1, N. Koizumi2, A. Ortiz3, K. Pai1, B. Bullock1, S. Sureddi1, J. Ortiz1

  • Comparative Analysis of Risk Factors and Outcomes in Kidney Transplant Recipients with Lung Cancer and Those with No Malignancy: UNOS Data Set

    H. Patel1, V. Nissaisorakarn2, E. Sula Karrecci1, N. Agrawal1, F. Cardarelli1

  • Comparative Analysis of Risks Factors for Kidney Allograft Loss Due to Bk Nephropathy and Graft Loss Due to Other Causes: UNOS Data Set

    H. Patel1, L. Kruger1, K. Agarwal1, A. Pawar1, N. Leeaphorn2, F. Cardarelli1, N. Agrawal1

  • Comparative Outcome Evaluation of Kidney Donors with and without Sickle Cell Trait

    A. Alshaqaq, N. Musaied, A. AlAbadi, M. AlBugami, F. AlOtaibi, K. Hamawi, K. Bel’eed-Akkari

  • Comparative Proteomics Analysis Identifies L-FABP as a Putative Biomarker of Graft Injury During Liver Transplantation Using the ITRAQ/MRM Approach

    M. Chen, Y. Zhang, M. Han, W. Ju, Q. Zhao, Y. Chen, D. Wang, X. He

  • Comparative Review of Adult Kidney Transplant Medicare Cost Report Reimbursement in U. S. Transplant Hospitals

    E. Zavala1, J. Rogers2, S. Karp1

  • Comparative Study between ATG and Grafalon as Induction Agent in Renal Transplant Recipient

    L. K. Das, P. Paudyal, S. Shrestha, B. Shahi, A. Pandey, R. Verma, P. Chandra Shrestha

  • Comparing Early Kidney after Liver Transplant (KALT) and Simultaneous Liver-Kidney Transplant (SLK): Evaluating Racial Disparities. Will Everyone Have the Same “Safety Net”?

    C. Jay1, R. Stratta1, W. Washburn2, J. Rogers1, S. Rudnick1, A. Reeves-Daniel1, J. Heimbach3

  • Comparing Post-Transplant Outcomes in Living and Deceased Donor Liver Transplantation for Patients with Hepatocellular Carcinoma: An Analysis of UNOS Registry

    T. Kitajima1, D. Moonka2, S. Yeddula1, M. Rizzari1, K. Collins1, A. Yoshida1, M. S. Abouljoud1, S. Nagai1

  • Comparing Surgical and Urological Complications Over Time in Deceased Donor Kidney Transplantation

    A. Mekhaimar, H. Maple, N. Mamode, R. H. Zakri, N. Kessaris

  • Comparing Two Methods of Minimally-Ischemic Cardiac Preservation in Life-Supporting Cardiac Xenotransplantation Model

    C. E. Goerlich1, A. Singh1, D. Kaczorowski1, M. Abdullah1, B. Lewis1, I. Tatarov1, A. Hershfeld1, T. Zhang1, E. Strauss1, P. Odonkor1, B. Williams1, D. Ayares2, B. Griffith1, M. Mohiuddin1

  • Comparing Weight-Based Dosing of Envarsus XR in Obese and Non-Obese Renal Transplant Recipients

    N. Breslin, N. Jandovitz, V. Nair, M. Abate, L. Teperman

  • Comparison of 1-Year Incidence of De Novo Donor Specific Antibodies between Thymoglobulin and Alemtuzumab Induction in Kidney Transplantation

    J. P. Knorr, C. Kallis, D. A. Portley, A. Jeyarajasingam, P. W. Lai, G. Bradauskaite, K. Khanmoradi

  • Comparison of 4 vs 14 Days Early Steroid Withdrawal in Kidney Transplant Recipients

    O. Adebiyi, J. Chen, B. Brady, S. Mietz, T. Taber, D. Mishler, M. Yaqub, W. Goggins, A. Sharfuddin

  • Comparison of Anti-Thymocyte Globulin and Alemtuzumab as Induction Therapy in Older Kidney Transplant Recipients

    M. Chaung, E. Hollinger, M. Brokhof, N. Alvey, L. Lineberger, N. Kenyon

  • Comparison of Basiliximab for Induction Therapy in Kidney Transplant Recipients on Post-Operative Days 0 and 4 versus Post-Operative Days 0 and 3

    C. Schardt, R. Yau, A. Burgos, C. Tunwar

  • Comparison of Clinical Characteristics and Outcomes of Early Antibody-Mediated Rejection and Late Antibody-Mediated Rejection after Kidney Transplantation

    G. Chen, Z. Wu, C. Wang, X. Liu, Q. Li, L. Chen

  • Comparison of Clinical Outcomes of Induction Regimens in Patients Undergoing Liver Transplantation for Acute Liver Failure

    C. M. Anugwom1, J. Parekh2, C. Hwang3, M. MacConmara3, W. M. Lee4, T. M. Leventhal1

  • Comparison of Intraoperative Cortical Renal Blood Flow after Reperfusion Using Laser Speckle Flowgraphy Device between Adult and Pediatric Kidney Transplants

    M. Muramatsu, K. Sakurabayashi, Y. Itabashi, Y. Takahashi, T. Mizutani, K. Nishikawa, T. Yonekura, H. Oguchi, K. Shinoda, Y. Hamasaki, T. Kawamura, K. Sakai, S. Shishido

  • Comparison of Metabolic Outcomes after Pancreas Transplantation between DBD (Donors after Brainstem Death) and DCD (Donors after Circulatory Death) Grafts

    J. Gopal, A. McLean, J. Crane, P. Herbert, F. Dor, M. Reddy, D. Taube, V. Papalois, A. Muthusamy

  • Comparison of One-Year Morbidity Following Liver Transplant for Acute Alcoholic Hepatitis vs. Alcoholic Cirrhosis

    O. M. Andacoglu1, U. Ozbek2, J. Liu3, C. Figueredo3, K. R. Chacko4, C. Tow4, J. F. Reinus4, M. Kinkhabwala1

  • Comparison of Oropharyngeal Candidiasis Outcomes in Renal Transplant Recipients Receiving Nystatin or No Antifungal Prophylaxis

    T. Q. Ky, L. Cotiguala, L. Fitzgerald, K. McMurry, J. Park, S. Tischer

  • Comparison of Outcome Between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation

    S. Kim, M. Lim, J. Kwon, E. Jeong, J. Yang, K. Kim, K. Lee, O. Lee, J. Joh

  • Comparison of Outcomes between Patients Bridged to Heart Transplantation with ECMO versus Those Not Bridged with ECMO During the Years 1985 to 2019

    D. J. Miklin1, A. D. Salimbangon2, G. S. Liu1, P. Banankhah1, P. A. Genyk1, P. Kingsford1, R. R. Chand3, J. P. Li1, D. Vucicevic4, A. S. Vaidya1, K. Pandya1, J. Rahman1, M. Fong1, L. Grazette1, A. Kiankhooy1, J. Nattiv1, S. Hashmi1, S. Nuno1, J. Pizula1, A. E. Lee1, K. Yang1, S. Shaw1, E. DePasquale1, W. M. Aaron5

  • Comparison of Prophylaxis Strategies for CMV Infection in Liver Transplant Recipients

    K. Schnelle, A. Leino, M. Chunduru, L. Von Stein, O. Witkowsky

  • Comparison of Reduced-Dose and Labeled-Dose Belatacept Conversion with Immediate or Early Tacrolimus Withdrawal in Kidney Transplant Recipients without Maintenance Corticosteroids

    H. Kuzaro1, A. R. Shields2, M. Cuffy2, E. S. Woodle1, K. Pembaur2, S. Safdar2, S. Huang2, G. Krisko2, S. Raabe2, R. Parks2, J. Kremer2

  • Comparison of Short-Term Outcomes of Induction Therapy with Alemtuzumab versus Rabbit Antithymocyte Globulin in Lung Transplantation

    V. Liu, M. W. Soto-Arenall, A. Patel

  • Comparison of Six-Month Outcomes in Patients Bridged to Heart Transplantation with Percutaneous Temporary Circulatory Support Before and after the UNOS Allocation System Change

    J. Nattiv1, G. S. Liu1, P. Banankhah1, J. Sussex1, P. Genyk1, J. Li1, D. Vucicevic2, R. S. Chand3, K. Pandya1, J. Rahman1, A. M. Wolfson4, A. S. Vaidya1, E. DePasquale1

  • Comparison of Specificity and Sensitivity of Clinical Viability Criteria to Assess Transplantability of High-Risk Donor Livers

    H. Mergental1, J. Hodson2, R. W. Laing1, Y. L. Boteon1, J. Attard1, L. Wallis3, A. Schlegel1, P. Muiesan1, M. Abradelo1, M. P. Perera1, D. Mirza4, S. C. Afford3

  • Comparison of Stanford Integrated Psychosocial Assessment for Transplantation Scores to Medication Adherence Assessment Findings in Kidney Transplant Candidates Undergoing Living Donor Transplant

    J. Trofe-Clark1, G. Malat1, M. Norris1, M. Bleicher2, E. Smith3, D. Sawinski2, R. Weinrieb4, R. Bloom2

  • Compatible Pairs- Providingan Option to Upgrade

    V. Chipman1, M. Cooper2, S. Flechner3, G. Hil4, D. Leeser5, D. Mandelbrot6, M. Ronin4, D. Segev7, S. Syed8, A. Thomas9, A. Waterman10, G. R. Roll11

  • Complement Activation and Delayed Graft Function after Kidney Transplantation

    C. Arias-Cabrales1, M. Pérez-Sáez1, M. Riera1, J. Gimeno2, D. Benito1, D. Redondo-Pachón1, A. Buxeda1, C. Burballa1, M. Crespo1, J. Pascual1, E. Rodríguez1

  • Compliance with OPTN Living Kidney Donor Follow-Up Policy Remains Low

    A. Thomas1, A. Shaffer2, D. Segev2, M. Henderson2

  • Computer-Assisted Cardiac Histologic Evaluation (CACHE) for Grading Cardiac Allograft Rejection

    E. Peyster1, S. ArabYarmohommadi2, A. Janowczyk2, M. Sekulic3, C. Cassol4, M. Feldman1, K. Margulies1, A. Madabhushi2

  • Concept Discussion: Five Experimental Stages to Establish the Methodologies for Organ Farming

    R. F. Smith

  • Concurrent Final Acceptance Associated with Decreased Deceased Donor Liver Utilization

    A. Robinson1, K. Shutterly2, M. Sellers3, J. Rosendale1, D. Brockmeier4

  • Consequences of Turning Down High KDPI Kidney Organ Offers for Kidney Transplant Candidates

    J. D. Motter, L. Liyanage, K. R. Jackson, M. G. Bowring, T. Ishaque, Y. Yu, S. Yu, J. M. Garonzik-Wang, A. B. Massie, D. L. Segev

  • Consistent Prevention of Perioperative Cardiac Xenograft Dysfunction with Non-Ischemic Cardiac Preservation in Life-Supporting Cardiac Xenotransplantation Model

    C. E. Goerlich1, A. Singh1, D. Kaczorowski1, M. Abdullah1, B. Lewis1, I. Tatarov1, A. Hershfeld1, T. Zhang1, P. Odonkor1, A. Tabatabai1, A. Bhutta1, E. Strauss1, B. Williams1, D. Ayares2, M. Mohiuddin1

  • Construction of Three-Dimensional Vascularized Functional Beta-Cells Tissues Using a Layer-by-Layer Cell Coating Technique

    S. Takaichi1, T. Akagi2, Y. Tomimaru1, S. Kobayashi1, Y. Iwagami1, H. Akita1, T. Noda1, K. Gotoh1, Y. Doki1, M. Akashi2, H. Eguchi1

  • Contamination of Acinar Cells Impairs Therapeutic Effect of Islet Transplantation Due to Induction of Inflammatory Reaction in Not Only Graft Islets but Also Hepatic Parenchyma

    K. Chinen, G. Yoshimatsu, N. Sakata, S. Kodama

  • Continuous Improvement in Long Term Survival of Kidney Transplants Over the Past Two Decades

    E. D. Poggio1, S. Arrigain2, A. Wee3, D. C. Brennan4, J. D. Schold2

  • Contract a Virus to Save a Life: A Comparison of Short Term Outcomes between Adult Hepatitis C Negative Kidney Transplant Recipients Receiving a Hepatitis C NAT Positive versus Hepatitis C Negative Deceased Donor Kidney

    H. Schaefer1, B. Concepcion1, A. Sudhakar2, S. Rega1, I. Feurer1, S. Shawar1, B. Dubrey1, D. Shaffer1, R. Forbes1

  • Contralateral Upper Tracturothelial Carcinoma after Primary Radical Nephroureterectomy in Kidney Transplant Patients

    Z. Wang, J. Lin, Y. Zhu, Y. Guo, Y. Tian

  • Contrary to Expectation, the Use of Immune Checkpoint Inhibitors is Not Consistently Associated with Early Onset Allograft Rejection in Solid Organ Transplant Recipients

    I. Owoyemi1, C. M. Costello2, C. Thongprayoon1, S. Markovic3, H. Joerg4, C. C. Otley5, T. Taner6, A. R. Mangold2, N. Leung1, S. Herrmann1, A. Kukla1

  • Conversion to a Belatacept Based Immunosuppression Regimen in Renal Transplant Recipients

    K. Paplaczyk, K. Cunningham, C. D'Agostino, D. Pinelli, J. Schulte, A. Shetty

  • Conversion to Belatacept (BLT)- from Calcineurin Inhibitor (CNI)-Based Immunosuppression During the First Year Post-Transplant (<1yr Tx) Increases Risk for CMV Infection Through Inhibition of Anti-CMV Humoral Immunity

    B. Shin, N. Ammerman, S. Sethi, A. Vo, S. C. Jordan, M. Toyoda

  • Conversion to Belatacept in HIV(+) Renal Transplant Recipients

    A. Santeusanio, A. Bhansali, R. Shapiro, G. De Boccardo

  • Conversion to Sirolimus to Prevent Recurrent Cytomegalovirus Infection/Disease: A Prospective and Randomized Trial

    L. Almeida Viana, M. Pontello Cristelli, G. Basso, D. Wagner Castro Lima Santos, M. Taver Costa Dantas, Y. Cardoso Dreige, L. Damasceno, M. Rika Nakamura, H. Tedesco-Silva, J. Medina-Pestana

  • Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Treatment of Patients with Hepatitis B Following Liver Transplantation

    C. Cheng

  • Cordycepin Protects Renal Ischemia/Reperfusion Injury Through Regulating Inflammation, Apoptosis and Oxidative Stress

    C. Ding, W. Xue

  • Correlation of CMV and EBV DNAemia in the Development of Invasive Fungal Disease among Pediatric Intestinal and Liver Transplant Recipients

    B. M. Chatani1, J. Garcia2, T. Beduschi3, A. Tekin3, R. Vianna3, I. A. Gonzalez1

  • Correlation of Intraoperative Donor Duodenal Segment Swab Cultures with the Subsequent Occurrence of Surgical Site Infections in Kidney-Pancreas Transplant Recipients

    C. M. Rotstein1, M. Alabdulla1, S. Al Rehily1, Y. Natori2, K. Van1, M. Cattral1, T. Reichman1

  • Cost Utilization and the Use of Pulmonary Functions Tests in Preoperative Liver Transplant

    M. LaGoy1, A. Ermekbaeva2, J. Buggs3, S. Nyce4, D. Patino4, E. Rogers3, A. Kumar1, N. Kemmer5

  • Cost-Effectiveness of Protocol Biopsies in Kidney Transplantation

    C. M. Puttarajappa, S. Hariharan, K. J. Smith

  • Costimulation Blockade-Based Maintenance Immunosuppression in a Sensitized Nonhuman Primate Kidney Allotransplantation Model

    R. Schmitz, Z. W. Fitch, P. M. Schroder, A. Y. Choi, M. Manook, J. Yoon, J. Kwun, S. J. Knechtle

  • Costimulatory Signal Impacts Car Treg Fate and Function in Transplantation

    B. Lamarthée1, A. Marchal1, S. Charbonnier1, T. Blein1, K. Vogt2, M. Titeux1, N. Pallet3, M. Delville1, E. Six1, D. Anglicheau4, C. Legendre4, B. Sawitzki2, J. Taupin5, M. Cavazzana1, I. André1, J. Zuber1

  • Creating a Patient Website to Search for Transplant Centers: www.transplantcentersearch.org

    C. R. Schaffhausen1, S. Chu2, M. Bruin3, A. Matas4, M. Hertz5, C. Martin5, J. Lake6, W. Kim7, S. Biggins8, J. J. Snyder9, B. L. Kasiske9, A. K. Israni10

  • Creation of a Low-Cost Kidney Transplant Surgery Simulator and Survey of its Utility for Education

    V. Melkonian, T. Huy, C. Varma, M. Nazzal, H. Randall, M. Nguyen

  • Crispr-Based Diagnostics for Rejection and Opportunistic Infection Detection in Kidney Transplantation

    I. T. Lape1, M. M. Kaminski2, E. Akalin3, J. Collins2, L. W. Riella1

  • Criteria for Simultaneous Liver-Kidney Transplantation: Is it Applicable for Simultaneous Heart -Kidney Transplantation?

    J. Yoo, D. Jain, A. Desai, S. Akkina

  • Cross-Sectional Survey to Assess Barriers to Medication Adherence in an Urban Transplant Population

    A. Reticker, B. Valdepenas, L. Glauner, O. Piatek, S. Kerns, P. West-Thielke

  • Cross-Validation of Performance-Based Frailty against Daily Step Count from Personal Activity Trackers – Refining Prehabilitation Tools in Liver Transplant Candidates

    M. A. Hassan1, M. A. Dunn1, P. M. Bloomer1, A. H. Gougol1, M. Serper2, D. R. Jorgensen1, A. Duarte-Rojo1

  • Crosstalk between TLR4 and HLA Class I Mediates P-Selectin Expression and Monocyte Capture to Endothelial Cells

    Y. Jin, N. M. Valenzuela, R. A. Sosa, E. F. Reed

  • Cryptococcosis In Kidney Transplant Recipients: A Multicenter Retrospective Case-Control Study

    L. Tardieu1, O. Lortholary2, F. Lanternier2, A. Scemla3, C. Rafat1

  • Cumulative United States Experience with Domino Liver Transplants

    A. Gruessner, J. Renz, S. Saggi, R. Gruessner

  • Current Status of Pre-Transplant Mortality in Pediatric Organ Transplantation

    G. Mazariegos1, E. Hsu2, .. OPTN Pediatric Committee3

  • Cyclo(His-Pro) Prevents Against Renal Injury Through Activating Nrf2-Mediated Pathway

    J. Moon1, Y. Kim1, H. Jung2, J. Kim1, W. Ju3, H. Lee1, J. Lee4, C. Lee5, D. Kim1, Y. Kim1, S. Yang6

  • Cyclophilin-D Inhibition Mitigates Cardiac Allograft Ischemia-Reperfusion Injury and Rejection

    A. Qamar1, P. McLeod2, J. Jiang2, X. Huang2, A. M. Jevnikar2, Z. Zhang2

  • Cytomegalovirus Infection and Disease in Pediatric Liver Transplantation: Burden of Disease Under a Preemptive Therapy Approach

    J. Arroyo-Orvañanos, J. A. Hernández-Plata, R. Erro-Aboytia, J. Nieto-Zermeño, A. Reyes-López, G. Varela-Fascinetto

  • Cytomegalovirus Infection and Outcomes in Pancreas Transplant Recipients in the Prophylaxis Era

    M. Jorgenson1, N. Marka2, G. Leverson2, J. Smith2, J. Odorico2

  • Cytomegalovirus Preemptive Monitoring Conversion and the Use of a Preemptive Threshold after Solid Organ Transplant

    C. Wong, M. Jorgenson, J. Descourouez, C. Saddler, J. Smith, D. Mandelbrot

Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences